Detalhe da pesquisa
1.
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Blood
; 138(22): 2278-2289, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265047
2.
R-BEAM versus Reduced-Intensity Conditioning Regimens in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma.
Biol Blood Marrow Transplant
; 26(4): 683-690, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682979
3.
Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts.
Am J Hematol
; 95(2): 198-204, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31691333
4.
Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.
Am J Hematol
; 94(10): 1072-1080, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292984
5.
A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.
Am J Hematol
; 93(4): E96-E98, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318650
6.
Impact of Pre-transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission.
Hematol Oncol Stem Cell Ther
; 16(2): 154-157, 2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425096
7.
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.
Transplant Cell Ther
; 29(3): 208.e1-208.e6, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584941
8.
Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review.
J Oncol
; 2022: 3472324, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36213836
9.
Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents.
Leuk Lymphoma
; 63(4): 813-820, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781825
10.
G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD.
Leuk Lymphoma
; 62(2): 446-453, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33043743
11.
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.
J Clin Oncol
; 39(18): 1971-1982, 2021 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905264
12.
Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma.
Leuk Lymphoma
; 61(8): 1877-1884, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270725
13.
Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome.
Leuk Lymphoma
; 60(11): 2762-2770, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010370
14.
Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
Bone Marrow Transplant
; 55(8): 1655-1657, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740765
15.
Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
Bone Marrow Transplant
; 54(1): 164-167, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30038352
16.
Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.
Leuk Res
; 83: 106171, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31228653
17.
Minimal residual disease as a predictive factor for relapse after allogeneic hematopoietic stem cell transplant in adult patients with acute myeloid leukemia in first and second complete remission.
Cancers (Basel)
; 4(2): 601-17, 2012 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24213327
18.
Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways.
Oncol Lett
; 2(4): 665-668, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22848246